# Type 1 Diabetes Prediction and Prevention (DIPP) Study

> **NCT03269084** · — · UNKNOWN · sponsor: **Riitta Veijola** · enrollment: 17000 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **OTHER:** No intervention. DIPP is an observational study.

## Key facts

- **NCT ID:** NCT03269084
- **Lead sponsor:** Riitta Veijola
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 1994-11-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 17000 (ESTIMATED)
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03269084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03269084, "Type 1 Diabetes Prediction and Prevention (DIPP) Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03269084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*